Ambry Genetics
Presencia
Konica Minolta es una de las ...
Konica Minolta es una empresa que cotiza bajo el símbolo de cotización 4902 (JP).
Konica Minolta tiene presencia directa en 12 países.Konica Minolta posee 16 subsidiarias incluyendo Ambry Genetics, Invicro y Konica Minolta Australia.
Ellos se encuentran en:
- Equipos de oficina65%
- Biotecnología18%
- Otro18%
Ejecutivos
Ver el organigrama con sus 8 ejecutivos principales
Biografías más buscadas en Ambry Genetics
- Tom Schoenherr, Chief Executive Officer
- Brigette Davis, Chief Operating Officer
- Michael Martinson, Chief Financial Officer
Recientes movimientos de ejecutivos en Konica Minolta
- Yusuke Yoshimura que es Corporate Senior Vice President, General Manager, FORXAI Business Operations, pasará a ser Senior Vice President and Executive Officer, Imaging Solution Business el 1 de abr.. de 2024 (noticia publicada el 5 de marzo de 2024).
- Hiroyuki Uemura que es Deputy General Manager, Quality Management Headquarters, pasará a ser Senior Vice President and Executive Officer, Corporate Quality Management el 1 de abr.. de 2024 (noticia publicada el 5 de marzo de 2024).
- Ken Osuga que es Corporate Senior Vice President, Strategic Project, pasará a ser Senior Vice President and Executive Officer, Business Development, Business Technologies el 1 de abr.. de 2024 (noticia publicada el 5 de marzo de 2024).
Haga clic aquí para ver otros movimientos en Konica Minolta
Crear su alerta
para seguir los movimientos de los ejecutivos en Ambry Genetics.
Biotecnología
Konica Minolta tiene 2.275 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Bruker has announced the acquisition of NanoString Technologies (publicado el 18 de abril de 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (publicado el 16 de abril de 2024).
- Nurix Therapeutics acaba de anunciar una recaudación de fondos de 175 millones de dólares. (publicado el 13 de abril de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Ambry Genetics
- Ambry Genetics Announces a Collaboration with Tempus to Advance Paired Germline and Somatic Testing Services for Medical Oncologists
- Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study
- LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for Clinical Implementation Pilots in Phase II of Singapore’s National Precision Medicine Programme
- Unilabs and Ambry Sign Agreement to Enhance Genetic Testing Services for Biopharma Companies in Europe, Latin America and the Middle East
- Ambry’s New Reproductive Health Program Uses Digital Platform to Make It Easier for Patients to Access Genetic Screening Before and During Pregnancy
- Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have Been Missed by DNA Testing Alone
- Konica Minolta Precision Medicine Announces Name Change to REALM IDx™ - Press Release | Ambry Genetics
- PRECEDE Consortium Announces Konica Minolta Precision Medicine as its Precision Health Partner to Advance its Mission to Increase Survival Rates for Patients with Pancreatic Cancer - Press Release | Ambry Genetics
- Ambry Genetics Leads in Clinical Contributions to GenCC, a Public Database to Inform the Relationship Between Various Genes and Diseases - Press Release | Ambry Genetics
- Konica Minolta Precision Medicine to Present on the Future of Integrated Diagnostics at AWS Healthcare & Life Science Virtual Symposium - Press Release | Ambry Genetics
- View more press releases Close
Redes sociales sobre Ambry Genetics
- Ambry Genetics en Wikipedia, Google News y Yahoo Finance
- Ambry Genetics en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Tom Schoenherr 
Llame a Ambry Genetics al +1 866...
